Murray IA - Search Results

1

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.

Moyer BJ, Rojas IY, Murray IA, Lee S, Hazlett HF, Perdew GH, Tomlinson CR. Moyer BJ, et al. Among authors: murray ia. Toxicol Appl Pharmacol. 2017 May 15;323:74-80. doi: 10.1016/j.taap.2017.03.012. Epub 2017 Mar 20. Toxicol Appl Pharmacol. 2017. PMID: 28336214 Free PMC article.

2

Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.

Kim DJ, Murray IA, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. Kim DJ, et al. Among authors: murray ia. J Biol Chem. 2005 Mar 11;280(10):9519-27. doi: 10.1074/jbc.M413808200. Epub 2005 Jan 4. J Biol Chem. 2005. PMID: 15632134 Free article.

3

Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity.

Murray IA, Reen RK, Leathery N, Ramadoss P, Bonati L, Gonzalez FJ, Peters JM, Perdew GH. Murray IA, et al. Arch Biochem Biophys. 2005 Oct 1;442(1):59-71. doi: 10.1016/j.abb.2005.07.014. Arch Biochem Biophys. 2005. PMID: 16137638

4

Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation.

Murray IA, Perdew GH. Murray IA, et al. J Pharmacol Exp Ther. 2008 Mar;324(3):1102-10. doi: 10.1124/jpet.107.132241. Epub 2007 Nov 30. J Pharmacol Exp Ther. 2008. PMID: 18055878 Free PMC article.

5

Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Shan W, Palkar PS, Murray IA, McDevitt EI, Kennett MJ, Kang BH, Isom HC, Perdew GH, Gonzalez FJ, Peters JM. Shan W, et al. Among authors: murray ia. Toxicol Sci. 2008 Oct;105(2):418-28. doi: 10.1093/toxsci/kfn142. Epub 2008 Jul 12. Toxicol Sci. 2008. PMID: 18622026 Free PMC article.

6

Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice.

Flaveny CA, Murray IA, Chiaro CR, Perdew GH. Flaveny CA, et al. Among authors: murray ia. Mol Pharmacol. 2009 Jun;75(6):1412-20. doi: 10.1124/mol.109.054825. Epub 2009 Mar 19. Mol Pharmacol. 2009. PMID: 19299563 Free PMC article.

7

Ah receptor represses acute-phase response gene expression without binding to its cognate response element.

Patel RD, Murray IA, Flaveny CA, Kusnadi A, Perdew GH. Patel RD, et al. Among authors: murray ia. Lab Invest. 2009 Jun;89(6):695-707. doi: 10.1038/labinvest.2009.24. Epub 2009 Mar 30. Lab Invest. 2009. PMID: 19333233 Free PMC article.

8

Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'-trimethoxyflavone.

Murray IA, Flaveny CA, DiNatale BC, Chairo CR, Schroeder JC, Kusnadi A, Perdew GH. Murray IA, et al. J Pharmacol Exp Ther. 2010 Jan;332(1):135-44. doi: 10.1124/jpet.109.158261. Epub 2009 Oct 14. J Pharmacol Exp Ther. 2010. PMID: 19828881 Free PMC article.

9

Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.

Murray IA, Morales JL, Flaveny CA, Dinatale BC, Chiaro C, Gowdahalli K, Amin S, Perdew GH. Murray IA, et al. Mol Pharmacol. 2010 Feb;77(2):247-54. doi: 10.1124/mol.109.061788. Epub 2009 Nov 10. Mol Pharmacol. 2010. PMID: 19903824 Free PMC article.

10

The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Schroeder JC, Dinatale BC, Murray IA, Flaveny CA, Liu Q, Laurenzana EM, Lin JM, Strom SC, Omiecinski CJ, Amin S, Perdew GH. Schroeder JC, et al. Among authors: murray ia. Biochemistry. 2010 Jan 19;49(2):393-400. doi: 10.1021/bi901786x. Biochemistry. 2010. PMID: 20000589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page